The best indicator for Stryker Corporation (SYK)
We backtested 20 indicators across daily, weekly and hourly charts on real Stryker Corporation (SYK) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the daily chart, this is the strongest risk-adjusted edge we found for Stryker Corporation (SYK) over ~46.2 years — trailing buy-and-hold by 6.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Daily | 13.2% | 0.66 | -53.0% | 74.3% | 183 | -6.5% |
| 2 | Money Flow Index ✓ | Daily | 10.9% | 0.66 | -50.0% | 79.3% | 58 | -8.8% |
| 3 | Heikin-Ashi Trend ✓ | Daily | 11.7% | 0.6 | -79.0% | 44.4% | 2231 | -8.0% |
| 4 | EMA 20/50 Cross ✓ | Weekly | 11.8% | 0.54 | -71.1% | 58.8% | 17 | -7.9% |
| 5 | SMA 50/200 Cross ✓ | Daily | 10.6% | 0.51 | -62.8% | 62.1% | 29 | -9.1% |
| 6 | EMA 50/200 Cross ✓ | Daily | 10.4% | 0.5 | -70.7% | 50.0% | 26 | -9.3% |
| 7 | Stochastic ✓ | Daily | 8.5% | 0.5 | -50.2% | 73.4% | 218 | -11.2% |
| 8 | CCI ✓ | Daily | 8.3% | 0.49 | -53.7% | 77.2% | 215 | -11.4% |
| 9 | Williams %R ✓ | Daily | 8.3% | 0.48 | -50.2% | 69.8% | 295 | -11.4% |
| 10 | Holy Grail Confluence ✓ | Daily | 7.7% | 0.48 | -51.0% | 78.9% | 76 | -12.0% |
| 11 | EMA 20/50 Cross | Daily | 8.9% | 0.47 | -56.4% | 43.0% | 114 | -10.8% |
| 12 | EMA-10 Trend ✓ | Daily | 8.2% | 0.46 | -64.9% | 41.6% | 1072 | -11.5% |
| 13 | Williams %R ✓ | Weekly | 7.0% | 0.46 | -48.9% | 78.0% | 59 | -12.6% |
| 14 | Donchian Midline ✓ | Weekly | 8.4% | 0.45 | -50.9% | 53.4% | 133 | -11.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Stryker Corporation (SYK), WaveTrend (8/6/4) on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.